Placebo of Rifaximin

DRUG2 trials

Sponsors

Judit Pich

Conditions

Cirrhoses, LiverLiver Cirrhoses

Phase 2

Simvastatin Plus Rifaximin in Decompensated Cirrhosis

CompletedNCT03150459

Judit PichCirrhoses, Liver

Start: 2017-07-26End: 2018-03-12Updated: 2019-03-28

Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development

CompletedNCT03780673

Judit PichLiver Cirrhoses

Start: 2019-01-03End: 2022-12-01Updated: 2023-05-24

Related Papers

Simvastatin and Rifaximin in Decompensated Cirrhosis

JAMA2025-02-0522 citations

Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease.

2023-01-2314 citations

Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.

2019-10-1099 citations